We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Precigen
PGEN
$2.45B
| $9.32K | ﹤0.01% |
6,561
+3,212
| +96% | +$4.55K |
|
352
ARS Pharmaceuticals
SPRY
$601M
| $9.27K | ﹤0.01% |
2,453
+1,211
| +98% | +$7.95K |
|
|
AMRN
353
Amarin Corp
AMRN
$297M
| $9.08K | ﹤0.01% |
494
+242
| +96% | +$5.25K |
|
354
Coherus Oncology
CHRS
$181M
| $9.07K | ﹤0.01% |
2,426
+1,193
| +97% | +$5.51K |
|
|
CNTA
355
DELISTED
Centessa Pharmaceuticals
CNTA
| $8.78K | ﹤0.01% |
1,357
+666
| +96% | +$4.56K |
|
356
Arbutus Biopharma
ABUS
$907M
| $8.72K | ﹤0.01% |
4,296
+2,119
| +97% | +$4.44K |
|
357
Arcutis Biotherapeutics
ARQT
$3.3B
| $8.44K | ﹤0.01% |
1,590
+785
| +98% | +$6.68K |
|
|
BLUE
358
DELISTED
bluebird bio
BLUE
| $8.35K | ﹤0.01% |
137
+67
| +96% | +$4.71K |
|
359
MaxCyte
MXCT
$136M
| $8.31K | ﹤0.01% |
2,663
+1,312
| +97% | +$5.28K |
|
|
TERN
360
DELISTED
Terns Pharmaceuticals
TERN
| $7.85K | ﹤0.01% |
1,560
+817
| +110% | +$5.18K |
|
361
Seres Therapeutics
MCRB
$47.4M
| $7.82K | ﹤0.01% |
164
+80
| +95% | +$6.11K |
|
362
Humacyte
HUMA
$179M
| $7.8K | ﹤0.01% |
2,661
+1,306
| +96% | +$4.32K |
|
363
PMV Pharmaceuticals
PMVP
$67.2M
| $7.68K | ﹤0.01% |
1,251
+651
| +109% | +$4.48K |
|
|
ME
364
DELISTED
23andMe Holding Co
ME
| $7.65K | ﹤0.01% |
391
+199
| +104% | +$5.58K |
|
365
Erasca
ERAS
$6.45B
| $7.63K | ﹤0.01% |
3,875
+1,899
| +96% | +$4.86K |
|
366
MeiraGTx Holdings
MGTX
$1.2B
| $7.47K | ﹤0.01% |
1,522
+743
| +95% | +$4.51K |
|
367
MacroGenics
MGNX
$256M
| $7.44K | ﹤0.01% |
1,597
+786
| +97% | +$3.91K |
|
368
Fulcrum Therapeutics
FULC
$284M
| $7.08K | ﹤0.01% |
1,594
+784
| +97% | +$3.43K |
|
|
IGMS
369
DELISTED
IGM Biosciences
IGMS
| $6.99K | ﹤0.01% |
837
+450
| +116% | +$3.82K |
|
370
Lexicon Pharmaceuticals
LXRX
$1.05B
| $6.85K | ﹤0.01% |
6,286
+3,801
| +153% | +$6.67K |
|
371
Xeris Biopharma Holdings
XERS
$1.55B
| $6.59K | ﹤0.01% |
3,541
+1,742
| +97% | +$3.99K |
|
372
Phibro Animal Health
PAHC
$1.37B
| $6.56K | ﹤0.01% |
514
+247
| +93% | +$3.5K |
|
|
GBIO
373
DELISTED
Generation Bio
GBIO
| $6.42K | ﹤0.01% |
170
+84
| +98% | +$3.98K |
|
374
Atea Pharmaceuticals
AVIR
$405M
| $6.42K | ﹤0.01% |
2,139
+1,046
| +96% | +$3.56K |
|
375
Ocular Therapeutix
OCUL
$2.25B
| $6.41K | ﹤0.01% |
2,040
+1,024
| +101% | +$4.19K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.